Related Experiment Video
Updated: Dec 10, 2025

09:33
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
Published on: July 28, 2013
29.0K
Corticospinal tract involvement in spinocerebellar ataxia type 3: a diffusion tensor imaging study
Bruno Shigueo Yonekura Inada1,2, Thiago Junqueira Ribeiro Rezende3, Fernando Vieira Pereira4
1Division of General Neurology and Ataxia Unit, Department of Neurology, Federal University of São Paulo (UNIFESP), São Paulo, Brazil. brunosy.inada@gmail.com.
Neuroradiology
|September 3, 2020
Summary
Diffusion tensor imaging (DTI) at 3 Tesla can detect corticospinal tract (CST) damage in spinocerebellar ataxia type 3 (SCA3). This microstructural damage correlates with ataxia severity, aiding disease understanding.
Area of Science:
- Neuroimaging
- Neurology
- Biomedical Engineering
Background:
- Spinocerebellar ataxia type 3 (SCA3) is a progressive neurodegenerative disorder.
- Corticospinal tract (CST) integrity is crucial for motor function.
- Diffusion tensor imaging (DTI) is a sensitive MRI technique for assessing white matter microstructure.
Purpose of the Study:
- To evaluate CST integrity in SCA3 patients using DTI.
- To investigate the correlation between CST microstructural abnormalities and ataxia severity.
Main Methods:
- Two cohorts of SCA3 patients and healthy controls were assessed using DTI at 1.5 T and 3.0 T.
- Fractional anisotropy (FA) values were analyzed across CST regions.
- Pearson's correlation was used to assess the relationship between DTI parameters and SARA scores.
Main Results:
- DTI at 1.5 T did not reveal significant differences between groups.
- DTI at 3.0 T showed significant reductions in FA values in multiple CST regions in SCA3 patients.
- Moderate correlations were observed between CST diffusivity parameters and ataxia severity in the 3.0 T cohort.
Conclusions:
- DTI, especially at 3.0 T, effectively detects and quantifies CST damage in SCA3.
- Microstructural damage in the CST is associated with the severity of ataxia in SCA3.
- These findings highlight the potential of DTI as a biomarker for disease progression and severity in SCA3.

